Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells.
about
Tumor-derived exosomes in cancer progression and treatment failureHeparin in malignant glioma: review of preclinical studies and clinical resultsHarnessing the genome for characterization of G-protein coupled receptors in cancer pathogenesisRho GTPases and their roles in cancer metabolismExosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor developmentRecapitulation of tumor heterogeneity and molecular signatures in a 3D brain cancer model with decreased sensitivity to histone deacetylase inhibitionHypoxic enhancement of exosome release by breast cancer cells.Plasma membrane-derived microvesicles released from tip endothelial cells during vascular sproutingCellular memory of hypoxia elicits neuroblastoma metastasis and enables invasion by non-aggressive neighbouring cells.Caspase-1-mediated pathway promotes generation of thromboinflammatory microparticles.Regulated delivery of molecular cargo to invasive tumour-derived microvesiclesActivation of protease-activated receptor 2 induces VEGF independently of HIF-1.Potential Coagulation Factor-Driven Pro-Inflammatory Responses in Ovarian Cancer Tissues Associated with Insufficient O₂ and Plasma Supply.Exosomal Proteome Profiling: A Potential Multi-Marker Cellular Phenotyping Tool to Characterize Hypoxia-Induced Radiation Resistance in Breast Cancer.A new mosaic pattern in glioma vascularization: exogenous endothelial progenitor cells integrating into the vessels containing tumor-derived endothelial cells.Extracellular Vesicles As Modulators of Tumor Microenvironment and Disease Progression in GliomaHypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis.Microparticles mediated cross-talk between tumoral and endothelial cells promote the constitution of a pro-metastatic vascular niche through Arf6 up regulation.Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo.Glioblastoma extracellular vesicles: reservoirs of potential biomarkers.Endothelial Angiogenesis and Barrier Function in Response to Thrombin Require Ca2+ Influx through the Na+/Ca2+ Exchanger.Extracellular membrane vesicles and immune regulation in the brain.Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases.Oncogenic extracellular vesicles in brain tumor progressionThe tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells.Putative Links Between Sleep Apnea and Cancer: From Hypotheses to Evolving Evidence.Sorting it out: regulation of exosome loadingProtease-activated receptors (PARs)--biology and role in cancer invasion and metastasis.The hypoxic tumor microenvironment: A driving force for breast cancer progression.CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cells.Extracellular Vesicles: Composition, Biological Relevance, and Methods of Study.Molecular pathways: tumor-derived microvesicles and their interactions with immune cells in vivoExosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid Raft-mediated endocytosis negatively regulated by caveolin-1.Hypoxia regulates the expression of tissue factor pathway signaling elements in a rat glioma model.Transfer of extracellular vesicles during immune cell-cell interactions.Emerging roles of extracellular vesicles in the adaptive response of tumour cells to microenvironmental stress.Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity.The critical role of the tumor microenvironment in shaping natural killer cell-mediated anti-tumor immunity.The reverse-mode NCX1 activity inhibitor KB-R7943 promotes prostate cancer cell death by activating the JNK pathway and blocking autophagic fluxTeleocidin A2 inhibits human proteinase-activated receptor 2 signaling in tumor cells.
P2860
Q26785408-A85A305B-5DF0-4EF8-BAA3-C24BE08836D6Q26821781-0889D2C2-2CC2-4231-B820-FE0F1F55B1A4Q26861766-16C31B6D-3AF9-4D5C-A4BF-0C5360FD6D07Q27003967-207326C9-EF84-4244-8681-4E3F8A41838EQ28397739-18E45692-F940-4916-949F-57F696E71DB1Q28484418-E1C5B518-0F37-4A0C-8C25-13F5B4085013Q30527905-DC531E29-710E-494D-9EA1-794B5E25C7B3Q30528297-B0925884-EFE8-4D52-86F1-6BEA83353A2DQ30621028-8355E517-06B0-4BB2-B32A-E290A677BBFDQ30639688-6CB87AC2-A412-4097-997B-FE76356A9716Q30657298-E091B51C-5FF5-4368-B620-390EDF47EE21Q31103929-27C00268-3DE3-46AA-B4B5-D6F132AC2E72Q33624680-D5ADC9CE-FD63-40D9-9C92-EB9346D6B1EEQ33644570-8E25D9E5-E77B-4A8F-9F51-AF153C062485Q33688374-299AEDF1-696E-47ED-B669-B6C216268D0BQ33876259-2CECBBBE-B9AD-4CA4-A739-0470F3A70C2FQ34025482-02107A20-05BA-4168-84EE-0AAB21ADA6CAQ34115934-9849C97E-1B7E-4644-933C-11F6F15CCFCBQ34354584-C5E409E0-19CC-484A-A11D-642E7F4B5D40Q35122209-5310408E-FEA4-4839-8AF6-38B187D9098BQ35883805-1B2ECBAB-3B19-4AA1-84DF-8851A94A5200Q35924477-0B4FEC98-F9E2-4198-9EF8-F0DAA2A1039DQ36081720-A599642C-2577-49FE-80C7-E6216229ED34Q36193774-D946C788-DA49-4666-A6B5-F65E0EA3CC97Q36208015-3568B492-533C-4828-8792-53B3191FA8B5Q36243213-A8FE3A84-56E3-47BA-B9EA-808A6B70D26DQ36267006-EDB559E5-6F5F-4400-8314-D4A430EE39E3Q36322931-4E2D6DA1-B03B-42D2-8650-7B283CFC9FC4Q36368931-1092FDF7-D6B0-4910-9695-615B63301E22Q36465278-7D8ECFCF-AD8C-46AF-A3D4-4520970634D3Q36647312-20438A2B-5316-471C-949D-A3DAB0F8DB6DQ36847231-CF093B23-473A-48E2-A7CE-C72EDFE809FDQ36929092-DDA27095-F96F-4463-B568-9A392C9BB701Q37001337-32870237-860F-4DEF-A31E-86B1DE5FE71FQ37087729-521689EA-6608-4400-A273-2EE3C0A8DFE0Q37141168-0F39F5CF-D524-43E9-8452-2069265A1146Q37256065-9056BEEE-544C-420D-8E38-1540F4B39036Q37413162-44D8FC91-0C1B-4E3F-BA3C-F7F7FF46398CQ37520442-A0312B84-C8AF-460B-8D27-2FCA0A611FD1Q37591794-AB0E492F-1782-483D-BA5D-4E0D4D629E60
P2860
Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Hypoxia triggers a proangiogen ...... ignaling in endothelial cells.
@ast
Hypoxia triggers a proangiogen ...... ignaling in endothelial cells.
@en
type
label
Hypoxia triggers a proangiogen ...... ignaling in endothelial cells.
@ast
Hypoxia triggers a proangiogen ...... ignaling in endothelial cells.
@en
prefLabel
Hypoxia triggers a proangiogen ...... ignaling in endothelial cells.
@ast
Hypoxia triggers a proangiogen ...... ignaling in endothelial cells.
@en
P2093
P2860
P50
P356
P1476
Hypoxia triggers a proangiogen ...... signaling in endothelial cells
@en
P2093
Helena C Christianson
Maria C Johansson
Matthias Mörgelin
Paulina Kucharzewska
Stefan Sköld
Tobias Löfstedt
Wolfram Ruf
P2860
P304
13147-13152
P356
10.1073/PNAS.1104261108
P407
P577
2011-07-25T00:00:00Z